Hadassah

Hadassah Stem Cell Pioneer Singled Out for Clinical Success

Thursday, Jul 6 2017

Dial back 20 years. Who was one of the first trailblazers in stem cell research?
Prof. Benjamin Reubinoff, head of the Hadassah Medical Organization’s Center for Human Embryonic Stem Cell Research, was not only a pioneer, but today is a physician/scientist whose innovative research has led to potentially promising treatments for patients suffering from debilitating diseases such as age-related macular degeneration (AMD).

Marking Prof. Reubinoff’s pivotal contribution to stem cell science almost eight years ago, Cell Stem Cell magazine chose to recognize his 2009 article in its tenth anniversary issue. Only one other author received that recognition.

As the magazine’s 10th anniversary editorial brings out, quite a few authors who publish their work in Cell Stem Cell  “dream that the work will eventually wind up in the clinic.” Prof. Reubinoff has witnessed the unfolding of that dream, along with his partner, Eyal Banin, head of Hadassah’s Center for Retinal and Macular Degenerations.

The 2009 article reveals their successful creation of retinal epithelium cells (RPEs) from human embryonic stem cells and the rescue of the retina’s structure and function in an animal model.

Today, Cell Cure, founded by Prof. Reubinoff, is tackling macular degeneration with a stem cell therapy that evolved from that work. Their Phase I/IIa clinical trial, now in progress, has shown that the cells they transplanted into the eyes of patients with AMD have engrafted with no major adverse reactions. And they have remained in place for at least a year.

Comments

No comments yet.
First Name
Email
Comment
Enter this word:

Related Stories

alt_text

Thursday, Jun 21 2018

Traveling with Ruth

Ruth Radiano, Head Nurse at Hadassah Hospital Mount Scopus, is an extraordinary woman, whose resume reads like a novel. I recently had the distinct pleasure of meeting her and hearing her speak, and in just five minutes with her, I felt as though I was with a Hadassah sister.

READ MORE ›
alt_text

Wednesday, Jun 20 2018

First in Israel: Hadassah Uses Innovative Technology to Treat Cancer in Spine

A multidisciplinary team at Hadassah Hospital Ein Kerem recently employed an innovative technology to treat cancer metastases near the spinal cord--a first for Israel.

READ MORE ›
alt_text

Tuesday, Jun 19 2018

American Journal of Ophthalmology Article Celebrates the Centennial of Hadassah Ophthalmology

The centennial anniversary of the Hadassah Medical Organization's Department of Ophthalmology is celebrated in the May issue of the American Journal of Ophthalmology, with an article by the immediate past director, Prof. Jacob Pe'er, and the current director, Prof. Itay Chowers.

READ MORE ›

Tuesday, Jun 12 2018

Hadassah Ophthalmology Department Research Highlighted by JAMA

Thanking the Hadassah Medical Organization’s researchers for their ”excellent submission” to JAMA Ophthalmology regarding a multi-center international study of the variable effectiveness of treatment for neovascular age-related macular degeneration (nAMD), the editors explained that their article was one of just a few from 12 JAMA on-line journals to be highlighted in The JAMA Network Reader this weekend.

READ MORE ›

Donation Questions

donorservices@hadassah.org

(800) 928-0685

Membership Questions

membership@hadassah.org

(800) 664-5646

Missions Department

missions@hadassah.org

(800) 237-1517

Contact Us

40 Wall Street

New York, NY 10005

support@hadassah.org

More ›

Show More